Drug Profile
Cisatracurium besilate
Alternative Names: 51W; 51W89; Nimbex; NombexLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer Abbott Laboratories; GSK
- Class Benzylisoquinolines; Muscle relaxants
- Mechanism of Action Neuromuscular blocking agents; Nicotinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Muscle hypertonia